Inogen Inc (INGN) stock
Close on Nov 13, 2026Market cap $151.00MP/E –Yield –
Inogen Inc grew revenue 13.7% to $379.32M over the twelve months to Sep 30, 2026. Free cash flow was -$11.33M. At the latest close the market valued the company at $151.00M.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $151.00M
- P/E ratio
- –
- Price to sales
- 0.40
- Price to book
- 0.96
- Dividend yield
- –
- Free cash flow yield
- -7.50%
Fundamentals
- Revenue
- $379.32M
- Net income
- -$35.46M
- EPS, diluted
- -$1.31
- Free cash flow
- -$11.33M
- Book value per share
- $5.93
- Diluted shares
- 26M
Trading
- Next earnings
- Feb 23, 2027 (estimated, during market hours)
- Previous close
- $5.62
- Open
- $5.60
- Day's range
- $5.55 – $5.71
- Volume
- 238,180
- Average volume (20 days)
- 300,913
- Index membership
- Russell 2000, Russell 3000
- Beta (5 years)
- 1.25
- 52-week range
- $5.04 – $7.67
- RSI (14 days)
- 36.6
- Volatility (1 year)
- 45.5%
- Relative volume
- 0.82×
- WACC
- 11.3%
On 1 of our idea list: More cash than they're worth
Index membership is inferred from the holdings of funds that track each index (IWM, IWV), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.
Market cap history
Month-end market cap since 2014, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | INGN | S&P 500 | Difference | INGN per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -10.3% | -3.0% | −7.2 pts | ||
| 3 months | -2.1% | -2.8% | +0.7 pts | ||
| Year to date | -15.3% | +11.5% | −26.8 pts | ||
| 1 year | -17.3% | +13.5% | −30.8 pts | ||
| 3 years | +17.1% | +77.7% | −60.6 pts | +5.4% | +21.1% |
| 5 years | -83.2% | +72.6% | −155.8 pts | -30.0% | +11.5% |
| 10 years | -91.1% | +308.2% | −399.2 pts | -21.4% | +15.1% |
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Inogen filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Update
- Results
- Update
- Results
About Inogen
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Inogen, Inc. is a medical technology company that develops, manufactures, and distributes respiratory health products. Its core offerings include portable oxygen concentrators such as the Inogen One and Inogen Rove systems, designed to deliver supplemental long-term oxygen therapy while allowing patient mobility. The company also distributes stationary oxygen concentrators, CPAP masks for obstructive sleep apnea, and the Simeox airway clearance device for mucus management. Inogen serves patients with chronic respiratory conditions such as chronic obstructive pulmonary disease, cystic fibrosis, and bronchiectasis. The business delivers products directly to patients through direct-to-consumer sales and rentals, while also supplying home medical equipment providers, distributors, resellers, and clinical facilities.
Company profile, executives and historyInogen stock: common questions
What is Inogen's stock price?
INGN closed at $5.69 on Nov 13, 2026, up 1.25% on the day. Over the past 52 weeks it traded between $5.04 and $7.67.
What is Inogen's market cap?
Inogen was worth $151.00M at the close on Nov 13, 2026: the share price times the diluted shares outstanding.
What is INGN's P/E ratio?
Inogen lost money over the twelve months to Sep 30, 2026 (diluted EPS -$1.31), so it has no meaningful P/E ratio.
How much revenue does Inogen make?
Inogen reported revenue of $379.32M for the twelve months to Sep 30, 2026, up 13.7% from a year earlier.
Does Inogen pay a dividend?
No. Inogen has not paid a cash dividend over the last twelve months.
When does Inogen report earnings next?
Inogen is expected to report Q4 FY2026 results on Feb 23, 2027, during market hours. The date is estimated from its past reporting pattern until the company confirms it.
How has INGN stock performed over the past year?
Including dividends, INGN returned -17.3% over the past year, against +13.5% for the S&P 500.
How many INGN shares are sold short?
1M shares were sold short at the latest FINRA report, 5.49% of the float, or 5.8 days of average trading volume.
Who are Inogen's competitors?
Companies most similar to Inogen by business, industry and size include TCMD, ESTA, ENOV, LAKE, INMD.
See a number that looks wrong?